Clinical Trial Update: ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

View source ↗

Summary

ABSORB FIRST is a registry evaluating the safety and performance of the Absorb Bioresorbable Vascular Scaffold in real-world coronary patients; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Restenosis
• Coronary Artery Stenosis
• Total Occlusion of the Coronary Artery

Drugs mentioned

• Absorb Bioresorbable Vascular Scaffold (Absorb BVS)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Total Occlusion of Coronary Artery, Coronary Occlusion | Status: COMPLETED | Results posted: 2016-10-19